Analgesics in France

Date: April 4, 2012
Pages: 45
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AB491A37CC2EN
Leaflet:

Download PDF Leaflet

Analgesics continued to be OTC medicines with which French consumers do not hesitate to self-medicate. In 2011, acetaminophen and in specific cases ibuprofen and ketoprofen continued to be preferred to aspirin.

Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts Globalwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN FRANCE

Euromonitor International
April 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2006-2011
  Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
  Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  Table 4 Analgesics Company Shares by Value 2007-2011
  Table 5 Analgesics Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Bayer Sante Familiale Sas in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 1 Bayer Santé Familiale SAS: Key Facts
  Summary 2 Bayer Santé Familiale SAS: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Bayer Santé Familiale SAS: Competitive Position 2011
Cooperation Pharmaceutique Francaise Sas (cooper) in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 4 Cooperation Pharmaceutique Francaise SAS (Cooper): Key Facts
  Summary 5 Cooperation Pharmaceutique Francaise SAS (Cooper): Operational Indicators
Company Background
Production
  Summary 6 Cooperation Pharmaceutique Francaise SAS (Cooper): Production Statistics 2011
Competitive Positioning
  Summary 7 Cooperation Pharmaceutique Francaise SAS (Cooper): Competitive Position 2011
Laboratoires Mcneil in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 8 Laboratoires McNeil: Key Facts
  Summary 9 Laboratoires McNeil: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 10 Laboratoires McNeil: Competitive Position 2011
Laboratoires Urgo SA in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 11 Laboratoires URGO: Key Facts
  Summary 12 Laboratoires URGO: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 13 Laboratoires URGO: Competitive Position 2011
Pierre Fabre Sa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 14 Laboratoires Pierre Fabre SA: Key Facts
  Summary 15 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
  Summary 16 Laboratoires Pierre Fabre SA: Production Statistics 2011
Competitive Positioning
  Summary 17 Laboratoires Pierre Fabre SA: Competitive Position 2011
Théraplix SA in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 18 Théraplix SA: Key Facts
  Summary 19 Théraplix SA: Operational Indicators
Company Background
Competitive Positioning
  Summary 20 Théraplix SA: Competitive Position 2011
Upsa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 21 Laboratoires UPSA: Key Facts
  Summary 22 Laboratoires UPSA: Operational Indicators
Company Background
Production
  Summary 23 Laboratoires UPSA: Production Statistics 2011
Competitive Positioning
  Summary 24 Laboratoires UPSA: Competitive Position 2011
Executive Summary
Consumer Health Registers Low But Positive Value Growth in 2011
Ageing Population and Concentration in Urban Areas, Key Growth Drivers
Direct Selling and Herbal Products Behind Best-performing Operators
Pharmacies Still the Most Common Retailer for Consumer Health Products
Modest Growth Expected Over the Forecast Period
Key Trends and Developments
Hectic Lifestyles Behind Good Performances of Some Categories of OTC Drugs
Ageing Population A Major Driver for Consumer Health
Weight Management, the Most Affected by the Weak Economic Context
Transfer of Rx Drugs To OTC Market Continues To Boost Growth Potential
French Consumers Increasingly Receptive To Oral Nrt Smoking Cessation Aids
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
  Summary 25 OTC - Switches 2009-2011
Definitions
Sources
  Summary 26 Research Sources
Skip to top


Bleach in France US$ 990.00 Jan, 2016 · 18 pages
Adult Mouth Care in France US$ 900.00 May, 2011 · 32 pages
Calming and Sleeping in France US$ 990.00 Jun, 2015 · 24 pages

Ask Your Question

Analgesics in France
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: